April 30th 2025
Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient satisfaction following bilateral implantation of an advanced presbyopia-correcting intraocular lens.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Cataract surgeons debate risks, benefits of blue-light-filtering IOLs
November 13th 2006Blue-light-filtering IOLs provide protection against potential blue light toxicity without significantly affecting clinical functioning of recipients, said James D. McCulley, MD, during a spotlight session on pseudophakic IOLs at the annual meeting of the American Academy of Ophthalmology.
Read More
Gold Micro-Shunt offers good IOP reduction without bleb
November 11th 2006The SOLX Gold Micro-Shunt (GMS, OccuLogix) is a novel approach to treating increased IOP in patients with open-angle glaucoma that does not respond to other therapies and is a good alternative to trabeculectomy, according to Shlomo Melamed, MD, an investigator based in Tel Aviv, Israel.
Read More
Gold Micro-Shunt offers good IOP reduction without bleb
November 11th 2006The SOLX Gold Micro-Shunt (GMS, OccuLogix) is a novel approach to treating increased IOP in patients with open-angle glaucoma that does not respond to other therapies and is a good alternative to trabeculectomy, according to Shlomo Melamed, MD, an investigator based in Tel Aviv, Israel.
Read More
Sealed capsule irrigation device helps prevent PCO development in small eyes
November 1st 2006Stockholm, Sweden-The Perfect Capsule (Milvella), a sealed capsule irrigation device, seems to be very useful in very small eyes for preventing posterior capsular opacification (PCO), according to Maria Kugelberg, MD, PhD.
Read More
Foldable phakic IOL corrects myopia
November 1st 2006Maastricht, The Netherlands-Preliminary results with the foldable iris-claw myopic phakic IOL (Artiflex, Ophtec) indicate it has a similar safety index when compared with the original polymethylmethacrylate (PMMA) model (Artisan, Ophtec), but is associated with less early induced refractive astigmatism, which results in a better efficacy index initially and shorter visual recovery curve, said Rudy M.M.A. Nuijts, MD, PhD.
Read More
Good functional vision in presbyopic patients is attainable
November 1st 2006Since our practice began offering presbyopia-correcting IOLs, we have implanted 450 of them. One in five of our cataract and refractive lens exchange patients chooses one of these new lenses. The AcrySof ReSTOR lens (Alcon Laboratories) accounts for 80% of our presbyopia-correcting implants, while the ReZoom (Advanced Medical Optics) and the crystalens (eyeonics) together represent 20%.
Read More
Presbyopic lens exchange for high myopia problematic
October 15th 2006Alicante, Spain-While one segment of the ophthalmic community sees presbyopic lens exchange for patients with high myopia as a promising, safe technique leading to good improvements in visual acuity, another segment does not, stating that the risk of retinal detachment and other complications related to the surgery are just too high, according to Jorge L. Alio, MD.
Read More
Safety favorable with pediatric primary IOL implantation
October 15th 2006Charleston, SC-Pediatric cataract surgery with IOL implantation and primary posterior capsulectomy plus vitrectomy is associated with a satisfactory outcome, especially in children operated on after their first birthday, said Rupal H. Trivedi, MD, MSCR.
Read More
Late optic calcification in hydrophilic acrylic lens poses vision risks
October 15th 2006Salt Lake City-Failure to recognize late opacification of the MemoryLens IOL (CIBA Vision) as a cause for vision problems can have potentially negative consequences, including unnecessary surgery and complications secondary to those procedures, said Jonathan G. Haymore, MD.
Read More
AMO's Tecnis CL replaces company's other silicone IOL models
October 4th 2006Advanced Medical Optics Inc. (AMO) launched its Tecnis CL silicone IOL, which reduces spherical aberrations, improves functional vision, and improves night-driving simulator performance. This IOL replaces the company’s Z9000 and Z9001 Tecnis silicone IOL models.
Read More
Could a multifocal IOL be the answer to patients' visual needs?
October 1st 2006The Tecnis multifocal IOL (Advanced Medical Optics) has been shown to be highly effective for patients with different clinical needs, such as in patients undergoing cataract surgery and IOL implantation, those with presbyopia, and in those with hyperopia. Three studies presented at the annual meeting of the American Society of Cataract and Refractive Surgery reported the results with this IOL.
Read More
Can cataract/refractive surgeons upgrade their customer service?
October 1st 2006Pleasanton, CA-Certain elements are key to building a successful lenticular refractive practice, according to Shareef Mahdavi, BA. While technology will continue to evolve, success with implants will likewise require physicians to evolve their approaches to the business side of refractive surgery, namely, upgrading their customer service.
Read More
Combination treatment may improve keratoconus/post-LASIK ectasia
October 1st 2006Minneapolis, MN-Early results are promising regarding the potential role of conductive keratoplasty (CK, Refractec) as an additional tool to improve vision outcomes in eyes with keratoconus or post-LASIK ectasia treated with corneal implants (Intacs, Addition Technology), said Jason K. Darlington, MD.
Read More
Aggressive treatment aids in corneal transplant rejection
October 1st 2006Cincinnati-"Regardless of whether we are talking about full-thickness transplants or endothelial transplants, corneal transplant rejection is the leading cause of graft failure," said Edward J. Holland, MD, director, Cornea and External Diseases, Cincinnati Eye Institute, Cincinnati.
Read More
Could a multifocal IOL be the answer to patients' visual needs?
October 1st 2006The Tecnis multifocal IOL (Advanced Medical Optics) has been shown to be highly effective for patients with different clinical needs, such as in patients undergoing cataract surgery and IOL implantation, those with presbyopia, and in those with hyperopia. Three studies presented at the annual meeting of the American Society of Cataract and Refractive Surgery reported the results with this IOL.
Read More
Accommodating IOL design modification reduces PCO
October 1st 2006Los Angeles-Preliminary results from a prospective study of patients with the crystalens square edge (SE) accommodating IOL (eyeonics) implanted suggest modification of the original optic edge design has been effective for reducing the development of posterior capsule opacification (PCO) and without causing an increase in visual quality-related complaints, according to D. Michael Colvard, MD.
Read More
Improving blepharoplasty results with careful observation
October 1st 2006Baltimore-Surgical results for patients requesting a blepharoplasty can be improved if the surgeon carefully examines individuals for coexisting diagnoses, pre-existing asymmetries, brow position, and lower eyelid malposition, explained Shannath L. Merbs, MD, PhD, FACS.
Read More
Tunnel creation examined as another femtosecond laser application
October 1st 2006Baltimore-Tunnel creation for placement of corneal implants (Intacs, Addition Technology) in eyes with corneal ectasia is a promising new use for the femtosecond laser (IntraLase FS, IntraLase), according to Alisa Kim, MD.
Read More
Botulinum toxin gains popularity for variety of disorders
September 15th 2006The use of botulinum toxin by ophthalmologists to treat a variety of disorders has exploded over the past several years. It has highlighted many issues of interest, including off-label use, supply charges, and cosmetic indications. All of these have important implications for coding, billing, and reimbursement.
Read More
Initial experience good with accommodating IOL
September 15th 2006San Francisco-In an initial analysis, the Synchrony dual-optic single-piece IOL (Visiogen) performed well. The visual results were good, there were no major complications and no glare or halos after implantation, and patient satisfaction was high, according to George Beiko, BM, BCh, FRCS.
Read More